Triple Negative Breast Cancer News and Research

RSS

New molecule offers a promising avenue to treat triple-negative breast cancer

A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer - a form of cancer that is notoriously aggressive and lacks effective treatments.

7 Nov 2025

Survival times continue to rise for people with advanced breast cancer

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in the US presented at the Advanced Breast Cancer Eighth International Consensus Conference (ABC8).

5 Nov 2025

Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment

A comprehensive review in "Biofunct. Mater." meticulously details the most recent advancements and clinical translation of intelligent nanodrugs for breast cancer treatment.

24 Oct 2025

Antibody discovery could provide new treatment options for aggressive breast cancers

A new potential antibody therapy strategy which restricts the growth of treatment-resistant breast cancers has been developed by scientists.

23 Oct 2025

New type of immunotherapy could change the treatment plan for triple-negative breast cancer

Triple-negative breast cancer is one of the most aggressive cancers. The name tells the story: It lacks the three main targets that make other types of breast cancers more treatable with powerful therapies.

22 Oct 2025

Fatty acids found to be a primary driver of triple-negative tumor growth

A team from Huntsman Cancer Institute at the University of Utah (the U) has found that triple-negative breast cancer is fueled by lipids and that these fatty acids are a key feature of obesity that promote tumor growth.

16 Oct 2025

Living near Superfund sites increases risk of aggressive breast cancer

Women living close to federally designated Superfund sites are more likely to develop aggressive breast cancers - including the hard-to-treat triple-negative subtype - according to new studies from Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine.

10 Oct 2025

Nanoparticle vaccine shows promise in preventing multiple cancers in mice

A study led by University of Massachusetts Amherst researchers demonstrates that their nanoparticle-based vaccine can effectively prevent melanoma, pancreatic and triple-negative breast cancer in mice.

9 Oct 2025

Perlmutter Cancer Center experts shine light on the rise of breast cancer in younger adults

Currently, breast cancer is the leading cause of cancer death in women age 20 to 49 in the United States. Compounding this concerning issue, younger patients are being diagnosed at more advanced stages, according to doctors at NYU Langone's Perlmutter Cancer Center, and this points to a greater need for screening, prevention, and breast cancer education.

9 Oct 2025

Study reveals new strategy to block TNBC metastasis and restore chromosomal stability

Triple negative breast cancer (TNBC) is one of the most aggressive and hardest forms of breast cancer to treat, but a new study led by Weill Cornell Medicine suggests a surprising way to stop it from spreading. Researchers have discovered that an enzyme called EZH2 drives TNBC cells to divide abnormally, which enables them to relocate to distant organs.

6 Oct 2025

New PET tracer enables rapid imaging of aggressive breast and bladder cancers

A promising new PET tracer can visualize a protein that is commonly overexpressed in triple-negative breast and urothelial bladder cancers within four hours, according to new research published in the September issue of The Journal of Nuclear Medicine.

22 Sep 2025

Triple negative breast cancer exploits lymph node niches to block immune defense

In almost all solid tumors - i.e. cancers with a solid tissue structure - the detection of tumor cells in the lymph nodes is considered a decisive marker for the progression of the disease.

16 Sep 2025

Sugar-coated nanoparticles offer new hope for treating triple-negative breast cancer

Triple-negative breast cancer is particularly aggressive and difficult to treat; but recent research may offer a new way to target the often-deadly disease.

3 Sep 2025

Landmark study maps mutational landscape of triple-negative breast cancer in African American women

Triple-negative breast cancer (TNBC), the deadliest breast cancer subtype, disproportionately affects African American women – but until now, they were underrepresented in genomic studies aimed at identifying the genetic mutations driving the disease.

1 Sep 2025

Combination treatment approach shows promise for hard-to-treat triple-negative breast cancer

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients with advanced triple-negative breast cancer (TNBC), one of the most aggressive and hard-to-treat forms of breast cancer.

21 Aug 2025

Triple Negative Breast Cancer News and Research

New molecule offers a promising avenue to treat triple-negative breast cancer

Survival times continue to rise for people with advanced breast cancer

Advancements and clinical translation of intelligent nanodrugs for breast cancer treatment

Antibody discovery could provide new treatment options for aggressive breast cancers

New type of immunotherapy could change the treatment plan for triple-negative breast cancer

Fatty acids found to be a primary driver of triple-negative tumor growth

Living near Superfund sites increases risk of aggressive breast cancer

Nanoparticle vaccine shows promise in preventing multiple cancers in mice

Perlmutter Cancer Center experts shine light on the rise of breast cancer in younger adults

Study reveals new strategy to block TNBC metastasis and restore chromosomal stability

New PET tracer enables rapid imaging of aggressive breast and bladder cancers

Triple negative breast cancer exploits lymph node niches to block immune defense

Sugar-coated nanoparticles offer new hope for treating triple-negative breast cancer

Landmark study maps mutational landscape of triple-negative breast cancer in African American women

Combination treatment approach shows promise for hard-to-treat triple-negative breast cancer

New formulation of chemotherapy drug opens doors to advanced cancer treatment options

UCSF researchers uncover how breast cancer steals energy from fat cells

Lactylation drives tumor progression and immune evasion in triple negative breast cancer

Plasma proteomics study unlocks predictive biomarkers for TNBC immunotherapy

DKK1 identified as key driver of immune resistance in bone metastases

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News